ALPHATEC HOLDINGS, INC. Revenue from Contract with Customer, Including Assessed Tax
ALPHATEC HOLDINGS, INC. (ATEC) reported Revenue from Contract with Customer, Including Assessed Tax of $213.51 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2026-08-04
- ALPHATEC HOLDINGS, INC. revenue from contract with customer, including assessed tax for the quarter ending 2026-06-30 was $213.51M, a 15.07% increase year-over-year.
- ALPHATEC HOLDINGS, INC. revenue from contract with customer, including assessed tax for the quarter ending 2026-03-31 was $192.11M, a 13.55% increase year-over-year.
- ALPHATEC HOLDINGS, INC. revenue from contract with customer, including assessed tax for the quarter ending 2025-12-31 was $212.93M, a 20.44% increase year-over-year.
- ALPHATEC HOLDINGS, INC. revenue from contract with customer, including assessed tax for the quarter ending 2025-09-30 was $196.50M, a 30.38% increase year-over-year.
- ALPHATEC HOLDINGS, INC. revenue from contract with customer, including assessed tax for fiscal 2025 was $764.15M, a 24.95% increase from fiscal 2024.
- ALPHATEC HOLDINGS, INC. revenue from contract with customer, including assessed tax for fiscal 2024 was $611.56M, a 26.81% increase from fiscal 2023.
- ALPHATEC HOLDINGS, INC. revenue from contract with customer, including assessed tax for fiscal 2023 was $482.26M, a 37.45% increase from fiscal 2022.
- ALPHATEC HOLDINGS, INC. revenue from contract with customer, including assessed tax for fiscal 2022 was $350.87M, a 44.26% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Including Assessed Tax 3 month | Revenue from Contract with Customer, Including Assessed Tax 6 month | Revenue from Contract with Customer, Including Assessed Tax 9 month | Revenue from Contract with Customer, Including Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $213.51M 10-Q · filed 2026-08-04 | $405.62M 10-Q · filed 2026-08-04 | $618.55M derived: sum of 3 quarters · filed 2026-08-04 | $815.05M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $192.11M 10-Q · filed 2026-05-05 | $405.04M derived: sum of 2 quarters · filed 2026-05-05 | $601.54M derived: sum of 3 quarters · filed 2026-05-05 | $787.08M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $212.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $409.43M derived: sum of 2 quarters · filed 2026-02-24 | $594.98M derived: sum of 3 quarters · filed 2026-08-04 | $764.15M 10-K · filed 2026-02-24 |
| 2025-09-30 | $196.50M 10-Q · filed 2025-10-30 | $382.05M derived: sum of 2 quarters · filed 2026-08-04 | $551.23M 10-Q · filed 2025-10-30 | $728.02M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $185.54M 10-Q · filed 2026-08-04 | $354.72M 10-Q · filed 2026-08-04 | $531.52M derived: sum of 3 quarters · filed 2026-08-04 | $682.24M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $169.18M 10-Q · filed 2026-05-05 | $345.97M derived: sum of 2 quarters · filed 2026-05-05 | $496.69M derived: sum of 3 quarters · filed 2026-05-05 | $642.26M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $176.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $327.51M derived: sum of 2 quarters · filed 2026-02-24 | $473.08M derived: sum of 3 quarters · filed 2026-02-24 | $611.56M 10-K · filed 2026-02-24 |
| 2024-09-30 | $150.72M 10-Q · filed 2025-10-30 | $296.29M derived: sum of 2 quarters · filed 2025-10-30 | $434.77M 10-Q · filed 2025-10-30 | $572.74M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $145.57M 10-Q · filed 2025-07-31 | $284.05M 10-Q · filed 2025-07-31 | $422.02M derived: sum of 3 quarters · filed 2026-02-24 | $540.28M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $138.48M 10-Q · filed 2025-05-01 | $276.45M derived: sum of 2 quarters · filed 2026-02-24 | $394.71M derived: sum of 3 quarters · filed 2026-02-24 | $511.63M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $137.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $256.23M derived: sum of 2 quarters · filed 2026-02-24 | $373.15M derived: sum of 3 quarters · filed 2026-02-24 | $482.26M 10-K · filed 2026-02-24 |
| 2023-09-30 | $118.26M 10-Q · filed 2024-10-30 | $235.18M derived: sum of 2 quarters · filed 2024-10-30 | $344.29M 10-Q · filed 2024-10-30 | $450.24M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $116.92M 10-Q · filed 2024-07-31 | $226.03M 10-Q · filed 2024-07-31 | $331.97M derived: sum of 3 quarters · filed 2025-02-26 | $421.81M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $109.11M 10-Q · filed 2024-05-07 | $215.05M derived: sum of 2 quarters · filed 2025-02-26 | $304.89M derived: sum of 3 quarters · filed 2025-02-26 | $389.04M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $105.94M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $195.78M derived: sum of 2 quarters · filed 2025-02-26 | $279.93M derived: sum of 3 quarters · filed 2025-02-26 | $350.87M 10-K · filed 2025-02-26 |
| 2022-09-30 | $89.84M 10-Q · filed 2023-11-06 | $173.99M derived: sum of 2 quarters · filed 2023-11-06 | $244.92M 10-Q · filed 2023-11-06 | $318.88M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $84.15M 10-Q · filed 2023-08-03 | $155.08M 10-Q · filed 2023-08-03 | $229.05M derived: sum of 3 quarters · filed 2024-02-27 | $291.93M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $70.93M 10-Q · filed 2023-05-04 | $144.90M derived: sum of 2 quarters · filed 2024-02-27 | $207.78M derived: sum of 3 quarters · filed 2024-02-27 | $270.02M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $73.96M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $136.84M derived: sum of 2 quarters · filed 2024-02-27 | $199.09M derived: sum of 3 quarters · filed 2024-02-27 | $243.21M 10-K · filed 2024-02-27 |
| 2021-09-30 | $62.88M 10-Q · filed 2022-11-03 | $125.13M derived: sum of 2 quarters · filed 2022-11-03 | $169.25M 10-Q · filed 2022-11-03 | $213.20M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $62.25M 10-Q · filed 2022-08-04 | $106.37M 10-Q · filed 2022-08-04 | $150.32M derived: sum of 3 quarters · filed 2023-02-28 | $191.49M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $44.12M 10-Q · filed 2022-05-05 | $88.08M derived: sum of 2 quarters · filed 2023-02-28 | $129.24M derived: sum of 3 quarters · filed 2023-02-28 | $158.87M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $43.95M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $85.12M derived: sum of 2 quarters · filed 2023-02-28 | $114.75M derived: sum of 3 quarters · filed 2023-02-28 | $144.86M 10-K · filed 2023-02-28 |
| 2020-09-30 | $41.16M 10-Q · filed 2021-11-04 | $70.79M derived: sum of 2 quarters · filed 2021-11-04 | $100.91M 10-Q · filed 2021-11-04 | $133.26M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $29.63M 10-Q · filed 2021-08-03 | $59.74M 10-Q · filed 2021-08-03 | $92.10M derived: sum of 3 quarters · filed 2021-08-03 | $121.30M derived: sum of 4 quarters · filed 2021-08-03 |
| 2020-03-31 | $30.11M 10-Q · filed 2021-05-06 | $62.47M derived: sum of 2 quarters · filed 2021-05-06 | $91.67M derived: sum of 3 quarters · filed 2021-05-06 | $118.99M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $32.35M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | $61.55M derived: sum of 2 quarters · filed 2021-03-05 | $88.87M derived: sum of 3 quarters · filed 2021-03-05 | $113.43M 10-K · filed 2021-03-05 |
| 2019-09-30 | $29.20M 10-Q · filed 2020-11-05 | $56.52M derived: sum of 2 quarters · filed 2020-11-05 | $81.08M 10-Q · filed 2020-11-05 | $106.42M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $27.32M 10-Q · filed 2020-08-06 | $51.87M 10-Q · filed 2020-08-06 | $77.22M derived: sum of 3 quarters · filed 2020-08-06 | $100.22M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $24.55M 10-Q · filed 2020-05-11 | $49.90M derived: sum of 2 quarters · filed 2020-05-11 | $72.90M derived: sum of 3 quarters · filed 2020-05-11 | $94.94M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $25.34M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | $48.34M derived: sum of 2 quarters · filed 2020-03-17 | $70.39M derived: sum of 3 quarters · filed 2020-03-17 | $91.69M 10-K · filed 2020-03-17 |
| 2018-09-30 | $23.00M 10-Q · filed 2019-11-01 | $45.04M derived: sum of 2 quarters · filed 2019-11-01 | $66.35M 10-Q · filed 2019-11-01 | |
| 2018-06-30 | $22.04M 10-Q · filed 2019-07-26 | $43.35M 10-Q · filed 2019-07-26 | ||
| 2018-03-31 | $21.31M 10-Q · filed 2019-05-10 | |||
| 2017-12-31 | $101.74M 10-K · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |